HOME >> BIOLOGY >> NEWS
After scrutiny, preemie lung treatments turn out to be safe, effective

Preemies between 28 and 32 weeks are not harmed by a treatment no longer used to help their lungs mature before birth, according to findings of a study in this months Pediatrics. Even though previous observational studies suggested that repeated courses of steroids in the womb may result in brain damage, this study shows that the babies brains are virtually unaffected.

"The consensus in recent years has been to no longer give women in preterm labor more than one course of steroids because of possible adverse effects, but it means more babies are born needing ventilation," said Sanjiv Amin, M.D., assistant professor of Pediatrics at the University of Rochester Medical center and author of the study. "These findings may give us back a tool to help give these fragile babies a better chance of survival."

Before concerns arose in 2000 about safety of multiple courses of steroids, many mothers in on-and-off preterm labor received several rounds before delivering. Now, when mothers go into preterm labor, obstetricians will often administer only a single course of steroids to help strengthen the babys lungs upon birth. But if the birth is successfully held off for more than seven days, the mother does not receive another course of medication and the babys lungs may not be protected.

This is regrettable, because one of the biggest challenges for babies born preterm is breathing on their own. Many develop respiratory distress syndrome because their lungs have not developed a protective film over their air sacks, called surfactant, which aids in the transfer of oxygen and decreases the work of breathing. Because of that, they may receive medications and supplemental oxygen, which can cause problems of their own. Some infants develop bronchopulmonary dysplasia, a scarring and inflammation of the lungs, from the oxygen treatment. Others can begin to leak air through the lungs and into the body cavity. Any of these complications, especially coup
'"/>

Contact: Heather Hare
heather_hare@urmc.rochester.edu
585-273-2840
University of Rochester Medical Center
5-Mar-2007


Page: 1 2 3

Related biology news :

1. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
2. After 2 years, study shows Revlimid patients live longer and remain transfusion free
3. After North Korea test, what can be done to reduce the growing nuclear threat?
4. After insects attack, plants bunker sugars for later regrowth
5. After the Hurricanes
6. After the yeast is gone bacteria continue to develop flavor of sparkling wine
7. After a time-shift, mixed signals from the circadian clock
8. After flu exposure, mild exercise protects mature mice from dying
9. Constant lighting may disrupt development of preemies biological clocks
10. UAB researchers find two surgical interventions for preemies have same effectiveness
11. Growth factor in baby formula could reduce NEC, most devastating GI disease in preemies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... ... (NGS) in microbial identification, played a key role in the award-winning study “Next ... by the Rothman Institute. The molecular diagnostic laboratory processed samples using Next Generation ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... form the leading provider of specialized histology, pathology, biomarker development, and archiving ... recently created by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical pharmacology and ... drug and disease strategic data analytics, has joined the firm as an Expert ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... ... its Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit ... San Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical ...
(Date:10/22/2019)... , ... October 22, 2019 , ... nQ Medical, Inc. ... School’s 2019 Most Fundable Companies List which was announced at a showcase event yesterday ... million in annual revenue, strong business plans, and impressive near-term growth projections to be ...
(Date:10/22/2019)... (PRWEB) , ... October 22, 2019 , ... ... biotherapeutics, has announced that its lead program, DBI-001, met its primary safety endpoints, ... open labeled phase 2a clinical trial for the treatment of interdigital tinea pedis ...
(Date:10/15/2019)... ... ... an award-winning tech PR agency at the epicenter of the future of PR, today announced ... in the Ragan’s Health Care PR & Marketing Awards. This award marks the second consecutive ... that its healthIT practice group grew by 18 percent in Q3 this year, driven by ...
Breaking Biology Technology:
Cached News: